ORI.AX

ORI.AX has a debt-to-equity ratio of 0.72 and a current ratio of 1.22, indicating moderate leverage and liquidity. The company's cash and equivalents amount to 746.7 million AUD, but this is offset by long-term debt of 3.0 billion AUD, resulting in a net cash position that is negative after subtracting total debt. The company's profitability metrics show a return on equity of 3.89% and a return on assets of 1.63%, which are below the industry median for commodity chemicals. This suggests that the company is underperforming in terms of capital efficiency and asset utilization. Geographically, the company's operations are concentrated in Australia, with no disclosed revenue breakdown by region. This concentration may expose the company to regional economic and regulatory risks. Looking at growth, the company's revenue for the latest period was 8.14 billion AUD. While the company has a positive operating cash flow of 949.2 million AUD, its free cash flow is only 22.9 million AUD, indicating that capital expenditures are consuming a significant portion of operating cash. The company faces moderate liquidity risk and low dilution risk. The risk assessment highlights that net cash is negative after subtracting total debt, which could impact the company's ability to fund operations without additional financing. Recent events include analyst estimates with a mean price target of 25.78 AUD and a median price target of 25.35 AUD. The mean recommendation is 1.79, indicating a generally positive outlook from analysts, with 3 strong-buy and 11 buy ratings.